In this article, we describe the ability of interleukin-34, a protein produced in excess in many cancers, to modulate the function of various immune cells, with the downstream effect of generating a tumor microenvironment that sustains cancer cell growth and, at the same time, enhances the resistance of cancers against chemotherapy and immunotherapy. This evidence concerns the gene IL34 and cancer.